Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_602d02d00daadbab08d46ac7a21506dd |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N3-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N3-084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N20-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H40-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06N3-08 |
filingDate |
2021-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86e0264e9d041cdff8eb5f13d819af9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e3be83d655018e8dbeea1d46d27ac2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9720ae433587321faac42b33c1d8dcad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0bbe84ece21983d8f84f22debb339f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bef1262eed82c44ccba8081fb767ddf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c850303d6b4e993b62f4e3325d51b6fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a81690535ba6d80c71dd5282906a4e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20ba64fcc9c21cd85081649c07c13968 |
publicationDate |
2021-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021225463-A1 |
titleOfInvention |
System and Method with Federated Learning Model for Medical Research Applications |
abstract |
The technology disclosed relates to a system and method of conducting virtual clinical trials. The system comprises a sponsor server configured to specify a target mapping of a clinical trial objective mapper. The target mapping maps participant-specific clinical data to an objective of a virtual clinical trial. The system comprises a plurality of edge devices accessible by respective participants in a plurality of participants. The system comprises a clinical trial conductor server configured to distribute coefficients of the clinical trial objective mapper to respective edge devices to implement distributed training of the clinical trial objective mapper. The clinical trial conductor server is configured to receive participant-specific gradients generated during the distributed training in response to processing participant-specific clinical data. The clinical trial conductor server is configured to aggregate the participant-specific gradients to generate aggregated gradients that cumulatively satisfy the target mapping of the clinical trial objective mapper. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114334158-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115249074-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023016845-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114092769-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2023289169-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2023253980-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115699207-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115242660-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116383344-A |
priorityDate |
2020-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |